The potential of neutrophil elastase inhibitors as anti-inflammatory therapies
PA Henriksen - Current opinion in hematology, 2014 - journals.lww.com
PA Henriksen
Current opinion in hematology, 2014•journals.lww.comClinical trials with neutrophil elastase inhibitors in lung and cardiovascular disease are
ongoing, and future studies will incorporate novel delivery approaches and be directed by
specific markers of neutrophil-derived elastase activity to target inhibition to the sites of
inflammatory tissue injury.
ongoing, and future studies will incorporate novel delivery approaches and be directed by
specific markers of neutrophil-derived elastase activity to target inhibition to the sites of
inflammatory tissue injury.
Summary
Clinical trials with neutrophil elastase inhibitors in lung and cardiovascular disease are ongoing, and future studies will incorporate novel delivery approaches and be directed by specific markers of neutrophil-derived elastase activity to target inhibition to the sites of inflammatory tissue injury.
Lippincott Williams & Wilkins